Reverse Transcription Free Microarray Analysis

Award Information
Agency:
Department of Health and Human Services
Amount:
$99,555.00
Program:
SBIR
Contract:
1R43GM074311-01
Solitcitation Year:
2005
Solicitation Number:
PHS2005-2
Branch:
N/A
Award Year:
2005
Phase:
Phase I
Agency Tracking Number:
GM074311
Solicitation Topic Code:
N/A
Small Business Information
SCI-TEC, INC.
10425 Cogdill Rd., #300, Knoxville, TN, 37932
Hubzone Owned:
N
Woman Owned:
Y
Socially and Economically Disadvantaged:
Y
Duns:
N/A
Principal Investigator
 YE SUN
 (865) 671-2166
 YE_SUN@SCIEN-TEC.COM
Business Contact
 VAL GOLOVLEV
Phone: (865) 671-2166
Email: golovlev@tds.net
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The goal of this project is to develop a new microarray system for performing gene expression analysis directly with total RNA without labeling and reverse transcription to cDNA. Achieving this goal will provide a critical breakthrough and establish a new standard in microarray field. Indeed, although microarray technique has been widely studied and proved to be successful in many applications, there are still many challenges in this field. First, the traditional microarray detection requires the total RNA to be reverse transcribed and labeled with reporter molecules, which is costly and time-consuming. Second, the PCR amplification of target sequences may give rise to systematic errors and biased hybridization signals. Third, the cost for a microarray instrumentation is high. Reducing the cost of instrumentation and day-by-day operation will make microarray technology more accessible to small research institutions and clinics. The key innovation of this project is a new RNA detection technique which employs electrostatic interaction of the target molecules and nanometer-size particles. This detection technique allows to use total RNA directly for hybridization experiment without reporter incorporation and reverse transcription from RNA to cDNA. The technique also allows inexpensive instrumentation to be used for highly-sensitive detection of DNA and RNA in gene expression analysis. With the recent reports of using microarrays in clinical tests for tumorogenesis and prognosis of a chemotherapy outcome (Science, 303:1754), introducing an advanced and inexpensive microarray platform will find fast adoption in more than 500 clinical laboratories and hundreds of life science research laboratories in US alone.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government